• Home
  • Store
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Social Work Courses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
    • Psychiatry News Videos
    • Medication Guide Videos
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • FAQs
  • Med Fact Book App
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Home » Shining a Light on PTSD

Shining a Light on PTSD

June 29, 2021
Edmund S. Higgins, MD.
From The Carlat Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue
Edmund Higgins, MD Dr. Higgins has disclosed no relevant financial or other interests in any commercial companies pertaining to this educational activity.

Review of: Youngstedt SD et al, Mil Med 2021 (Epub ahead of print)


Study type: Randomized, sham-controlled trial


As stated in the previous brief, PTSD is difficult to treat, and numerous interventions for PTSD have failed with veterans. This study took a different approach; it is the first randomized controlled trial of light therapy for PTSD.


Conducted at the VA Medical Center in Columbia, South Carolina, this study randomized 69 veterans with combat-related PTSD (from Afghanistan and/or Iraq) to 4 weeks of morning bright light treatment or a placebo. Those with a history of winter depression were excluded.


Light therapy consisted of 30 minutes of 10,000 lux ultraviolet-filtered white light within one hour of arising. The placebo was an inactivated negative ion generator, which has been used to control for light therapy in other studies. Participants were blindly rated on the Clinician-Administered PTSD Scale (CAPS) and Clinical Global Impressions scale (CGI). Self-reported measures of depression, anxiety, side effects, and sleep were elicited at baseline and upon completion of the study. Sleep variables were indirectly measured via continuous wrist actigraphic recording. Approximately two-thirds of the participants in the study were simultaneously receiving other treatments for PTSD. The study was funded by the VA.


Bright light significantly improved CAPS and CGI scores, with a large effect size (1.1) compared to placebo. Additionally, significantly more subjects receiving bright light achieved a response (reduction > 33%) compared to placebo (44.1% vs 8.6%). However, no participant achieved remission from PTSD. Remarkably, scores for depression, anxiety, and sleep did not differ between treatment and control. There were no significant side effects with light therapy, though headache and eye strain can occur and it should be used with caution in ocular disease. Although the subjects were not blinded to their treatment, there was no significant difference in expectation of improvement between treatment and control.


Most mental illnesses, including PTSD, are associated with circadian rhythm abnormalities, which may explain some of these benefits. Light therapy also modulates serotonin. However, this doesn’t explain why sleep and depression did not improve with light therapy.


We reached out to the lead author (Youngstedt), who shared his impression that light therapy improved symptoms unique to PTSD.


TCPR’s Take
This well-designed study found bright light therapy made a meaningful difference in veterans with combat-related PTSD. Although it’s only one study, we don’t have many options for this population, and light therapy has a good safety record in depression. Consider it in patients who want a non-medication approach, and in those with seasonal depression (see TCPR Feb 2019 for directions on light therapy).

General Psychiatry
KEYWORDS complementary-treatments light-therapy lightbox natural-treatments ptsd randomized-controlled-trial research research-update seasonal_affective_disorder trauma
    Edmund S. Higgins, MD.

    Stranger to Ourselves

    More from this author
    www.thecarlatreport.com
    Issue Date: June 29, 2021
    SUBSCRIBE NOW
    Table Of Contents
    CME Post-Test - Depression, TCPR, June/July 2021
    Note From the Editor-in-Chief
    Disulfiram: An Underused Strategy for Alcohol Use Disorders
    Psychotherapy and Medication in Recurrent Depression
    How to Write an Open Note
    Genetic Testing: What You Need to Know in 2021
    Two Negative Studies of Mirtazapine and Riluzole for PTSD in Veterans
    Shining a Light on PTSD
    DOWNLOAD NOW
    Featured Book
    • MFB7e_Print_App_Access.png

      Medication Fact Book for Psychiatric Practice, Seventh Edition (2024) - Regular Bound Book

      The updated 2024 reference guide covering the most commonly prescribed medications in psychiatry.
      READ MORE
    Featured Video
    • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
      General Psychiatry

      KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

      Read More
    Featured Podcast
    • shutterstock_2622607431.jpg
      General Psychiatry

      Should You Test MTHFR?

      MTHFR is a...
      Listen now
    Recommended
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png
    • Join Our Writing Team

      July 18, 2024
      WriteForUs.png
    • Insights About a Rare Transmissible Form of Alzheimer's Disease

      February 9, 2024
      shutterstock_2417738561_PeopleImages.com_Yuri A.png
    • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

      May 24, 2024
      DEA_Checkbox.png

    About

    • About Us
    • CME Center
    • FAQ
    • Contact Us

    Shop Online

    • Newsletters
    • Multimedia Subscriptions
    • Books
    • eBooks
    • ABPN Self-Assessment Courses

    Newsletters

    • The Carlat Psychiatry Report
    • The Carlat Child Psychiatry Report
    • The Carlat Addiction Treatment Report
    • The Carlat Hospital Psychiatry Report
    • The Carlat Geriatric Psychiatry Report
    • The Carlat Psychotherapy Report

    Contact

    carlat@thecarlatreport.com

    866-348-9279

    PO Box 626, Newburyport MA 01950

    Follow Us

    Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

    © 2025 Carlat Publishing, LLC and Affiliates, All Rights Reserved.